Medical News

RSS
Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

NASDAQ issues Staff Determination letter to Hythiam

NASDAQ issues Staff Determination letter to Hythiam

Scientists explore the fundamental basis of the lateral-line sensory system

Scientists explore the fundamental basis of the lateral-line sensory system

ABAM addresses the need for treating patients with addiction issues by introducing a new certification

ABAM addresses the need for treating patients with addiction issues by introducing a new certification

Ecological restoration in areas of environmental degradation can help reverse global biodiversity losses

Ecological restoration in areas of environmental degradation can help reverse global biodiversity losses

Weight loss competition to be held to bring a new focus on healthy living

Weight loss competition to be held to bring a new focus on healthy living

Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories

Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories

Leading experts in health and health care reform to take part in symposium

Leading experts in health and health care reform to take part in symposium

Options for insurance are few in some states: BestWeek U.S./Canada

Options for insurance are few in some states: BestWeek U.S./Canada

Foresight integrates eEmergence's HIPAA 5010 interpretive content into its products

Foresight integrates eEmergence's HIPAA 5010 interpretive content into its products

Banfield Veterinary Clinical Center Student Commons dedicated in honour of the Naimoli family by WesternU

Banfield Veterinary Clinical Center Student Commons dedicated in honour of the Naimoli family by WesternU

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

NASDAQ Stock Market issues delisting notice to American Bio Medica Corporation

NASDAQ Stock Market issues delisting notice to American Bio Medica Corporation

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

Chiropractor and nutritional educator receives Excellence in Nutritional Education award

Chiropractor and nutritional educator receives Excellence in Nutritional Education award

AAAHC re-accredits Associated Dental Care Providers

AAAHC re-accredits Associated Dental Care Providers

Rebuilder Medical Technologies is in concluding stages of finalizing a national contract to provide billing services for all physicians

Rebuilder Medical Technologies is in concluding stages of finalizing a national contract to provide billing services for all physicians

New contract agreement reached between Stanford Hospital & Clinics, Packard Children’s hospital and the SEIU-UHW union

New contract agreement reached between Stanford Hospital & Clinics, Packard Children’s hospital and the SEIU-UHW union

Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495

Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.